Surgical Oncology

Surgicoll-Mesh®

Surgical Oncology

Implantable, bioresorbable, tissue regenerative sterile Type-I Collagen Acellular Dermal Matrix designed for reconstructive breast surgery, oral cancer and precancerous lesion repair.

Surgicoll-Mesh product box

Intra Oral Cancer

Commonly Affected Sites

Oral cancer can develop at multiple sites within the oral cavity and oropharynx. The most frequently involved locations include:

Common Oral Cancer Sites

  • Tongue (lateral border)
  • Floor of the Mouth
  • Lips
  • Buccal Mucosa (inner cheek)
  • Hard & Soft Palate
  • Gingiva (gums)
  • Oropharynx
  • Retromolar Trigone

Pre-cancerous lesions such as leukoplakia (white patches) and erythroplakia (red patches) often precede malignant transformation and are critical to identify during routine dental or clinical examinations.


Surgical excision site
Defect closure with conventional collagen
Post-operative tissue healing
4 Weeks post-op healing using conventional collagen
Intraoral lesion status
Defect Closure with Surgicoll-Mesh®
Matrix application phase
4 weeks post-op healing using surgicoll-Mesh®

Comparison of Novel Matrix-Modified Bovine Collagen Membrane (SurgiColl-Mesh®) vs. Conventional Collagen - Oral Mucosal Defects

P Kalyani, Selvarasu K, Murthykumar K, Krishnan M, Kumar SP, Lakshmanan S. Cureus. 2024 Feb 6;16(2):e53696. doi: 10.7759/cureus.53696. PMID: 38455829; PMCID: PMC10918302.

Phase 1 double-blind randomized controlled clinical trial (CTRI-REF/2023/12/076231). 20 patients divided into two equal groups.

  • Group 1: Novel SurgiColl-Mesh®
  • Group 2: Conventional bovine collagen membrane

Parameters assessed at 2 weeks: epithelialization, granulation tissue formation, and wound contraction. Independent sample t-test conducted at 95% confidence interval.

SurgiColl-Mesh® (Group 1)
Epithelialization
35%
Granulation
35%
Wound Contraction
40%
Conventional Collagen (Group 2)
Epithelialization
10%
Granulation
30%
Wound Contraction
10%

SurgiColl-Mesh® has an average porosity of 20 microns (vs. >800 microns in conventional membranes), yielding better cell infiltration and regenerative factor availability. No adverse reactions occurred in either group.

p = 0.015 Epithelialization - Statistically Significant
p = 0.015 Granulation Tissue - Statistically Significant
p = 0.005 Wound Contraction - Statistically Significant

Surgical excision remains the cornerstone of oral cancer treatment. Following tumour removal, reconstruction of the defect site is essential for restoring form and function.

Bioresorbable collagen matrices such as Surgicoll-Mesh® (Sheet Form) represent an innovative approach to oral cancer excision repair. Acting as a scaffold that is naturally and progressively integrated, remodelled, and eventually replaced by functional host tissue, they offer clear advantages over synthetic alternatives in supporting healing after oncological surgery.

Clinical Evidence in Oral Mucosal Defects

Case: Verrucous Carcinoma

Pre-op oral cancer, surgical defect of verrucous carcinoma
Surgical Defect of Verrucous carcinoma
Application of Surgicoll-Mesh
Application of Surgicoll-Mesh®
Post-op healing at surgical site after 2 months
Post-Op 2 months
Good healing at the surgical site

Evaluation of Bovine-Derived Collagen Membrane in Oral Surgical Mucosal Defects

Shanmugam D, Dominic N. J Maxillofac Oral Surg. 2019 Sep;18(3):466-473. doi: 10.1007/s12663-018-1172-6. Epub 2018 Nov 17. PMID: 31371892; PMCID: PMC6639437.

A clinical study evaluating the effectiveness of bovine-derived collagen (Surgicoll-Mesh®, 0.5 mm) in surgical oral mucosal defects. Thirty-two patients (8 female, 24 male, ages 18–65) who underwent surgery for benign, premalignant, and malignant oral cavity lesions were enrolled from 2012–2018. Cases included leukoplakia, oral submucous fibrosis (OSMF), mucocele, fibromas, and malignant lesions.

The membrane was soaked in normal saline for a minimum of 5 minutes, adapted to the mucosal defect, trimmed with scissors, and secured with 3-0 Vicryl sutures. Patients were evaluated at Day 3, 7, 30, and 3 months using the Bessho et al. scoring criteria.

Parameter Good Fair Poor
Haemostasis 81.25% 18.75% 0%
Pain Relief 68.75% 31.25% 0%
Granulation Tissue 87.5% 12.5% 0%
Epithelialisation 93.75% 6.25% 0%
Contracture Control 62.5% 25% 12.5%
Overall Effectiveness 81.25% 18.75% 0%

Within 1 week, 75% of patients reverted back to normal eating habits. No allergic reactions were reported in any patient.

32
Patients Enrolled
81.25%
Overall Effectiveness — "Very Effective"
93.75%
Good Epithelialisation at 1 Month
0%
Patients Rated Ineffective

Case 2: Oral Cancer Excision Treatment

Mouth not openable beyond 10 mm
Mouth Opening ≤10 mm
Surgicoll-Mesh secured using sutures
Surgicoll-Mesh® secured using sutures
Healing Progress – Day 7
Granulation Tissue Formation – Day 7
Mouth opens beyond 20 mm – Day 14
Mouth Opening >20 mm – Day 14
Complete Healing - Day 32
Good Patient Recovery
Complete Healing - Day 32 additional view
Complete Healing - Day 32

Case 3: Treatment of Left Retromolar Trigone of Mandibular Cancer

Incision site marked for tumor removal
Placement of Surgicoll-Mesh®
Surgicoll-Mesh® secured by sutures
Granulation Tissue Formation - Day 3
Significant Healing - Day 11

Case 2 & 3
Courtesy of Dr. Pradeep, Oral Oncologist, Nagercoil

Case 4: Treatment of Oral Granuloma

Granuloma Hyperplasia of the Upper Lip
Surgicoll-Mesh® secured by sutures
Evidence of Successful Healing - 5 Months

Courtesy of Dr. Mohammed Zuhaib MDS (OMFS), MFD RCSI (Ireland), MFDS RCPS (Glasgow), Fellow Oral Oncosurgery

Watch Surgicoll-Mesh® in Intra Oral Cancer

See the clinical application of Surgicoll-Mesh® in the management of post-surgical mucosal defects following oral cancer excision. The membrane becomes soft and supple when hydrated with normal saline, mimicking native tissue.

The collagen membrane is secured with 3-0 Vicryl sutures and quilted to accommodate wound drainage. Patients typically return to normal oral feeding from the 3rd post-operative day, with the membrane undergoing resorption by day 7 revealing healthy epithelial tissue underneath.

Surgicoll-Mesh® for Intraoral Cancer Reconstruction

Video thumbnail

Breast Cancer Reconstruction

What is Breast Cancer Reconstruction?

Breast cancer reconstruction (also called breast reconstruction surgery) is a surgical procedure used to rebuild the shape, appearance, and symmetry of the breast after breast cancer treatment, usually after a mastectomy (removal of the breast) or lumpectomy (partial removal of breast tissue).

Shape Restoration

Helps restore the natural contour and structure of the breast.

Symmetry Support

Improves balance and appearance after treatment.

Post-Surgery Recovery

Supports physical and emotional healing after cancer care.

Breast Cancer Excision Site Reconstruction by SURGICOLL-MESH®

Tumor Excision
Excision Site
Collagen Scaffold Placement
Tissue Regeneration
Final Reconstruction

SURGICOLL-MESH® bridges the gap left after tumor excision. Once placed, the bioresorbable collagen matrix acts as a temporary scaffold that extends the pectoralis muscle, giving surgeons a stable structure for implant-based reconstruction. Over the following weeks, the patient's own cells migrate into the matrix, new blood vessels form, and the scaffold is gradually resorbed and replaced by natural tissue—restoring breast contour with a result that looks and feels like the patient's own.

Prospective Multicenter Clinical Trial Findings

Regenerative High Purity Type I Collagen Scaffold for Breast Cancer Excision Repair and Reconstruction
Krishnappa R, Narayan N, Narasimhamurthy A, Deep SS. Cureus. 2026 Mar 21;18(3):e105608. doi: 10.7759/cureus.105608. PMID: 41868445; PMCID: PMC13005701.

Intraoperative Steps for Using a Regenerative High Purity Type-I Collagen Scaffold for Breast Cancer Excision Repair and Reconstruction

Clinical Trial Image 1

Skin marking of the breast tumour with concurrent axillary dissection in progress.

Clinical Trial Image 2

Post-excision defect in the upper outer quadrant demonstrating the residual cavity after tumour resection.

Clinical Trial Image 3

Hydration and preparation of the high-purity type I collagen scaffold prior to implantation.

Clinical Trial Image 1

Placement of the high-purity type I collagen scaffold into the excision cavity to restore volume.

Clinical Trial Image 2

Scaffold fixation secured with absorbable sutures to surrounding breast parenchyma.

Clinical Trial Image 3

Completed layered skin closure. following scaffold implantation.

The Challenge

Breast-conserving surgery (BCS) causes volume displacement defects, asymmetry, and contour deformities that significantly lower post-operative patient satisfaction scores. Standard tissue substitutes carry donor site morbidity.

Efficacy Findings

Implantation of the HPTC scaffold immediately following excision provides stable volume restoration, excellent early structural retention, and clear radiologic integration visible on imaging follow-up.

Safety Profile

Demonstrated to be a completely safe and biologically active matrix option, showing high cosmetic satisfaction scores with minimal complications, zero allergic reactions, and no tissue rejection across all study patients.

Clinical Documentation Vault

Review or download comprehensive specifications, product literature, and peer-reviewed publications.

Surgicoll-Mesh® Available Sizes

Choose from our wide range of standard sizes (in cm). Custom sizes available on request.